TABLE 2.
Etiologies of renal failure and details of CRRT
| Patient | Etiology of renal failurea | Urine output/ 24 h (ml)b | Type of CRRT | Blood flow rate (ml/min)b | Dialysis rate (ml/h)bcd | Ultrafiltration rate (ml/min)bd | Concomitant vasoactive drug(s) |
|---|---|---|---|---|---|---|---|
| 1 | Ischemic ATN | 0 | CVVH | 150 | 19 ± 2 | Dopamine | |
| 2 | ATN 2° unknown etiology | 134 | CVVH | 150 | 9 ± 8 | None | |
| 3 | Hepatorenal syndrome | 12 | CVVH | 150 | 19 ± 4 | Dopamine | |
| 4 | Sepsis with MODS | 155 | CVVH | 150 | 15 ± 2 | Dopamine, norepinephrine | |
| 5 | Idiopathic thrombocytopenia purpura | 35 | CVVH | 150 | 17 ± 12 | None | |
| 6 | Cardiogenic shock | 0 | CVVHDF | 150 | 957 ± 81 | 18 ± 2 | Dopamine, isoproteranol |
| 7 | Sepsis with MODS | 29 | CVVHDF | 150 | 857 ± 227 | 20 ± 10 | Norepinephrine |
| 8 | Ischemic ATN | 0 | CVVHDF | 150 | 940 ± 28 | 14 ± 1 | Dopamine, norepinephrine |
| 9 | ATN 2° unknown etiology | 0 | CVVHDF | 150 | 954 ± 47 | 20 ± 4 | Epinephrine |
| 10 | Rhabdomyolysis | 67 | CVVHDF | 150 | 970 ± 161 | 23 ± 7 | None |
| 11 | ATN 2° sepsis with MODS | 43 | CVVHDF | 150 | 1,000 ± 0 | 13 ± 2 | Dopamine, norepinephrine |
| 12 | Cardiogenic shock | 0 | CVVHDF | 150 | 1,020 ± 26 | 14 ± 2 | Dopamine, epinephrine |
ATN, acute tubular necrosis; 2°, secondary; MODS, multiple-organ dysfunction syndrome.
During time of pharmacokinetic sampling.
Applicable only to patients receiving CVVHDF.
Rates shown as means ± standard deviations.